Sagimet Biosciences
CA - San MateoBiotechnology
Focus: Sagimet Biosciences is a pre-revenue biotech focused on fatty acid synthase (FAS) inhibitors targeting metabolic diseases, oncology, and infectious diseases. The company operates as a small, private clinical-stage organization based in San Mateo, CA.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
4
Should You Work at Sagimet Biosciences?
AI assessmentSagimet offers early-stage upside and scientific novelty but lacks the financial transparency, hiring scale, and publication track record needed to assess sustainability and career stability.
Why Work Here
- Working on a differentiated mechanism (FAS inhibition) with applicability across three major therapeutic areas (metabolic disease, oncology, infectious disease), offering scientific depth and cross-functional exposure
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Denifanstat
HealthyClinical Trials (1)
NCT07216313A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
Phase 1Help build intelligence for Sagimet Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.